GO
Loading...

Regulations

More

  • Technology that could save you from a truck wreck Wednesday, 30 Jul 2014 | 7:00 AM ET
    A Volvo truck equipped with safety technology.

    Truck companies are banking on the safety features of their vehicles as a selling point.

  • Barclays chief applauds claw-back idea on bonuses Wednesday, 30 Jul 2014 | 4:24 AM ET

    LONDON— The CEO of Barclays said having provisions to claw back bankers' bonuses, as outlined by regulators on Wednesday, is a good idea in principle. Antony Jenkins told the BBC that such provisions are useful, though he was awaiting the details. Jenkins has made corporate responsibility a key pillar of his tenure at Barclays, Britain's second-biggest bank.

  • July 30- A federal grand jury for the Northern District of California charged PG&E Corp on Tuesday alleging it obstructed the investigation of the National Transportation Safety Board into the deadly San Bruno natural gas explosion in 2010..

  • Tri-state coal interests rally before hearings Wednesday, 30 Jul 2014 | 2:06 AM ET

    PITTSBURGH— More than 2,000 union workers and others organized by the coal industry in Pennsylvania, Ohio and West Virginia joined top state elected officials Wednesday to rally against proposed stricter federal pollution regulations for coal-burning power plants.

  • July 29- A federal grand jury for the Northern District of California charged PG&E Corp on Tuesday alleging it obstructed the investigation of the National Transportation Safety Board into the deadly San Bruno natural gas explosion in 2010..

  • Impax Labs shares slump after FDA inspection Tuesday, 29 Jul 2014 | 3:38 PM ET

    NEW YORK— Shares of Impax Labs sank Tuesday after an FDA inspection uncovered potential problems at a facility where the company will make its experimental Parkinson's disease drug Rytary. Impax has been unable to get marketing approval for Rytary because of problems stemming from FDA inspections.

  • WASHINGTON/ NEW YORK, July 29- The long-anticipated merger of Sprint Corp and T-Mobile US Inc is not expected to occur before September, with the companies continuing due diligence and preparing a detailed case for a deal before U.S. regulators, according to people familiar with the matter.

  • JPMorgan paying $650K to settle CFTC charges Tuesday, 29 Jul 2014 | 1:47 PM ET

    WASHINGTON— JPMorgan Chase will pay $650,000 to settle charges by federal regulators that it filed inaccurate reports on the trading positions of some of its large customers.

  • *FDA lists 10 violations at Taiwan plant. July 29- Impax Laboratories Inc said the U.S. Food and Drug Administration raised concerns about the company's factory in Taiwan, casting in doubt the future of its Parkinson's drug, rytary.

  • LONDON, July 29- Somewhere in an office at the Bureau of Industry and Security in Washington, D.C., a mid-ranking government official is sitting down with a stack of dictionaries.

  • WASHINGTON, July 29- A U.S. appeals court on Tuesday rejected a food industry challenge to a federal rule concerning labeling requirements for meat, a ruling that could have a major impact on businesses fighting federal regulation on free-speech grounds.

  • Telecom shares rise after Windstream gets REIT approval Tuesday, 29 Jul 2014 | 10:51 AM ET

    July 29- Shares of U.S. telecom companies rose after network operator Windstream Holdings Inc said it got regulatory approval to convert some of its assets into a REIT- a tax-efficient structure that could be followed by others.

  • WASHINGTON, July 29- A U.S. appeals court on Tuesday rejected for a second time a food industry challenge to a federal regulation that specifies labeling requirements for certain meat products.

  • Suzuki recalls 25,900 Verona sedans in U.S. Tuesday, 29 Jul 2014 | 10:14 AM ET

    DETROIT, July 29- Suzuki Motor Corp is recalling 25,900 Verona sedans from the 2004 to 2006 model years in the United States on the increased risk of a fire linked to daytime running lights, U.S. safety regulators said on Tuesday.

  • July 29- Impax Laboratories Inc said the U.S. Food and Drug Administration issued certain observations regarding violations in the company's manufacturing plant in Taiwan. Shares of Impax, which makes generics and specialty drugs to treat central nervous system disorders, fell about 17 percent to $23.15 premarket on Tuesday.

  • U.S. FDA raises concerns about Impax's Taiwanese plant Tuesday, 29 Jul 2014 | 8:18 AM ET

    July 29- Impax Laboratories Inc said the U.S. Food and Drug Administration issued "certain observations" after an inspection of the company's manufacturing plant in Taiwan. "The FDA did not provide any status or classification to these observations," the company said. It closed at $28.03 on Monday.

  • China investigating Microsoft in monopoly case Tuesday, 29 Jul 2014 | 7:57 AM ET

    BEIJING— China's anti-monopoly agency announced an investigation Tuesday of Microsoft Corp., stepping up regulatory pressure on foreign technology companies.

  • BEIJING, July 29- A Chinese regulator said on Tuesday it is conducting an anti-monopoly investigation into Microsoft Corp over its Windows operating system, in the latest in a growing number of competition probes that have unnerved Western firms in China.

  • Living in a bank settlement world     Tuesday, 29 Jul 2014 | 7:31 AM ET

    There's been a tremendous increase in the states getting involved in areas of regulations they did not usually get involved in before, says Eric Dinallo, Debevoise & Plimpton LLP partner, discussing banking regulations.

  • FRANKFURT/ ZURICH, July 29- Germany's Deutsche Bank and Switzerland's UBS said they were caught up in an inquiry by U.S. regulators, who are looking into whether broker-run stock exchanges gave an unfair advantage to high-frequency traders.